VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Novartis AG vs Reckitt Benckiser Group plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Novartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisReckitt Benckiser Group plc
RKT · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Reckitt Benckiser Group plc's moat claims, evidence, and risks.
View RKT analysisComparison highlights
- Moat score gap: Novartis AG leads (65 / 100 vs 63 / 100 for Reckitt Benckiser Group plc).
- Segment focus: Novartis AG has 5 segments (29.3% in Oncology); Reckitt Benckiser Group plc has 3 segments (70.8% in Core Reckitt).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Novartis AG has 4 moat types across 3 domains; Reckitt Benckiser Group plc has 5 across 3.
Primary market context
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Reckitt Benckiser Group plc
Core Reckitt
Branded consumer health and hygiene (self-care OTC, intimate wellness, germ protection, household care)
Global
Consumers via mass retail, e-commerce and pharmacy channels
Branded consumer goods manufacturer / brand owner
70.8%
Side-by-side metrics
Moat coverage
Shared moat types
Novartis AG strengths
Reckitt Benckiser Group plc strengths
Segment mix
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Reckitt Benckiser Group plc segments
Full profile >Core Reckitt
Oligopoly
Essential Home
Competitive
Mead Johnson Nutrition
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.